Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07213830) titled 'A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity and Anti-tumour Activity of IPN01203 in Adults With Locally Advanced or Metastatic Solid Tumours Exposed to Immune Checkpoint Inhibitor Therapies' on Oct. 1.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Sequential Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Ipsen
Condition:
Advanced Solid Tumor
Metastatic Solid Tumor
Intervention:
Biological: IPN01203
Recruitment Status: Not recruiting
Phase: Phase 1/Phase 2
Date of First Enrollment:...